Mr. Gallagher has more than 25 years of experience in the life science and biotech industry with a focus on corporate development, marketing and venture investing. He’s held leadership roles including Co-Founder, Board Director and Chief Business Officer with several biotech companies including: Retrosense Therapeutics (acquired by Allergan), Zavante Therapeutics, OrPro Therapeutics, Kalyra, Immusoft and Zeno Pharmaceuticals. Currently he serves on the board of directors of Zeno Pharma, VelosBio, SelectION and Ocuphire. Prior to these roles he held management positions at Verus Pharma, CV Therapeutics and Dura Pharma. Mr. Gallagher holds an M.B.A. from the University of San Diego and a B.S. in Business Administration from Ohio University.